(Q45871191)

17 December 2017

title

Immune tolerance for haemophilia patients with inhibitors: analysis of the western United States experience. The Tri-Regional Nursing Group (English)

1 reference

17 December 2017

main subject

hemophilia

0 references

United States of America

0 references

author name string

Damiano ML

series ordinal

1

1 reference

17 December 2017

Hutter JJ Jr

series ordinal

2

1 reference

17 December 2017

publication date

1 September 2000

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

526-532

1 reference

17 December 2017

Epidemiology of inhibitors in haemophilia A.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

The international registry of immune tolerance: 1994 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

Immune tolerance: a synopsis of the international experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

Inhibitors to coagulation: can we afford immune tolerance induction regimens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

Tolerance induction using the Malmö treatment model 1982-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

Implantable venous access devices in children with hemophilia: a report of low infection rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

The use of implantable venous access devices (IVADs) in children with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

Central venous catheter infection in haemophiliacs undergoing prophylaxis or immune tolerance with clotting factor concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00412.X

10.1046/J.1365-2516.2000.00412.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017